Navigation Links
Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6
Date:8/30/2010

Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 -... -- CHENGDU, China, Aug. 30 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Pharmaceuticals, Supplementary Medicine, Trade Show News Click to view news release full screen  

Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6

 

CHENGDU, China, Aug. 30 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a biopharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine, branded generics will participate in the Roth Fall Conference from September 1 - September 6 at Grand Wailea Resort Hotel, Maui, Hawaii.

Dr. James Jiayuan Tong, Tianyin's Chief Financial Officer, Chief Business & Development Officer and Director is invited to present in two following panel discussions at the conference.

CFO Essentials -- Updates And Practical Implications For CFOs of U.S.-Listed Chinese Companies

Wednesday, September 1, 2:30 pm - 4:00 pm, Haleakala Ballroom China Social Infrastructure Panel Thursday, September 2, 10:00 am - 10:55 am, Haleakala Ballroom

About Tianyin Pharmaceuticals

Tianyin Pharmaceutical Co., Inc., headquartered at Chengdu, China, is a biopharmaceutical company that specializes in the development, manufacturing, marketing and sale of patented biopharmaceutical medicine, modernized traditional Chinese medicines and branded generics. Tianyin currently manufactures a comprehensive portfolio of 56 products, of which 23 are listed in the national medicine reimbursement list, 7 are included in the essential drug list of China. Tianyin currently has a pipeline of 10 late stage products pending the SFDA approval that target various high incidence healthcare indications. Tianyin has an extensive nationwide distribution network with a sales force of 720 sales representatives out of totaled 1,365 employees. For more information about Tianyin, please visit http://www.tianyinpharma.com .

Safe Harbor Statement

The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.

For more information, please contact: Tianyin Pharmaceutical Co., Inc. James Jiayuan Tong M.D. Ph.D. Chief Financial Officer, Chief Business & Development Officer Director Add: 23rd Floor Unionsun Yangkuo Plaza No 2 Block 3 South Renmin Road Chengdu, 610041 China Tel: +86-28-8551-6696 (Chengdu, China) +86-134-3655-0011 (China) +1-949-350-6999 (U.S.) Email: Dr.Tong@tianyinpharma.com Web: http://www.tianyinpharma.com
'/>"/>

SOURCE Tianyin Pharmaceutical Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing
2. Tianyin Pharmaceutical Co., Inc. to Host Third Fiscal Quarter 2010 Results Earnings Conference Call on Wednesday, May 12, 2010 at 9:00 a.m. ET
3. Tianyin to Present at 5th Annual Biomedical Forum by Sino American BioPharmaceutical Association
4. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
5. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products
6. Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
7. Tianyin Pharmaceutical, Co. Announces Cash Dividend to Common Shareholders - Record Date October 30, 2009
8. Mindray to Attend the 2010 American Association for Clinical Chemistry Conference
9. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
10. Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp
11. Inverness Medical Innovations to Attend the Jefferies 2010 Global Life Sciences Conference on June 8, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... 9, 2016  Landauer, Inc. (NYSE: LDR ), ... and monitoring, outsourced medical physics services and high quality ... fiscal 2016 first quarter ended December 31, 2015. ... 2016 First Quarter Highlights , Revenue of $36.5 ... of 2015 , Domestic Radiation Measurement services revenues increased ...
(Date:2/9/2016)... , Feb. 9, 2016  Jazz Pharmaceuticals plc ... report its 2015 fourth quarter and full year financial ... of the financial markets.  Company management will host a ... p.m. EST/9:30 p.m. GMT to discuss fourth quarter and ... and financial update and guidance for 2016 financial results. ...
(Date:2/9/2016)... Amarantus BioScience Holdings, Inc. ... for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference ... New York City . The Company,s presentation ... 12:30 pm by Gerald E. Commissiong , President ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 2016 , ... It’s that time of year when most people have forgotten ... Athletic Association of Maryland (IAAM), Hall of Fame athlete and Garrison Forest School athletic ... , That’s why one of her first decisions when her IAAM two-year presidency began ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... and production of its newest mobility device, the StandUp Walker. Made entirely in ... design in the last 50 years. , StandUp Walker’s novel patent-pending design offers ...
(Date:2/9/2016)... New York, NY (PRWEB) , ... February 09, 2016 , ... ... announce the appointment of Dr. David Hung to the company´s Board of Directors. ... is a world class scientist and an exceptional entrepreneur.” said Juan Jose Chacon Quiros, ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... to expand access to affordable hearing aids , increase industry transparency, and ... in the United States. , “For the average consumer, the hearing aid industry ...
(Date:2/9/2016)... ... 09, 2016 , ... Sir Grout, the leading hard surface ... announce that many of their franchises have received the Super Service Award from ... franchises received customer recognition through positive reviews and testimonials, as well as evaluations ...
Breaking Medicine News(10 mins):